Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

NCT02109562 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

354

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: RBP-7000
DRUG: Placebo
DRUG: Risperidone

Sponsor

Indivior Inc.